Whoop launches a new blood test focused on women's health | TechCrunch

Last day to exhibit your breakthrough to 10,000+ tech leaders at Disrupt is on Oct 2. Book Exhibit Table Now. Disrupt doors open Oct. 13. Get your pass and bring someone with you at 50% off. REGISTER NOW. Fitness wearable maker Whoop is launching a new panel focused on women’s health through its Whoop Labs blood testing service. The company is also adding a new feature to its app that surfaces information about hormonal changes during menstrual cycles. The startup said the panel includes 11 blood biomarkers that can give insights into aspects such as cycle regulation and hormonal transitions: Anti-Müllerian Hormone (AMH), Progesterone, Prolactin, Thyroid Peroxidase Antibodies (TPOAb), Free T4, Free T3, Leptin, Vitamin B12 (Cobalamin), Folate, Magnesium, and Phosphate (as Phosphorus). The company claims measuring these biomarkers will help users understand more about perimenopause, thyroid function, nutrient sufficiency, and bone metabolic resilience, when paired with data on activity, sleep, and recovery. The test will be available to users for purchase from next month. When Whoop launched its blood testing service in September 2025, it had over 350,000 people on the waitlist. Mean